1. 1. Skolnick P, Legutko B, Li X, Bymaster FP. Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 2001; 43(5): 411-23.
2. 2. Kulkarni SK and Dhir A. Current investigational drugs for major depression, Expert Opin Investig Drugs 2009; 18(6): 767-88.
3. 3. Lee TS, Quek SY and Krishnan KR. Molecular Imaging for Depressive Disorders, AJNR Am J Neuroradiol 2014; 35(6): 44-54.
4. 4. Arciniegas DB, Anderson CA, Topkoff J, McAllister TW. Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment, Neuropsychiatr Dis Treat 2005; 1(4): 311–327.
5. 5. Duman RS. Pathophysiology of depression and innovative treatments: remodelling glutamatergic synaptic connections, Dialogues in Clinical neuroscience 2014; 16: 11-27.